Terms: = Thyroid cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Clinical Outcome
4 results:
1. TMPRSS4 is a novel biomarker and correlated with immune infiltration in thyroid carcinoma.
Xu X; Sun T; Jing J
BMC Endocr Disord; 2022 Nov; 22(1):280. PubMed ID: 36380313
[TBL] [Abstract] [Full Text] [Related]
2. Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4.
Zhu MX; Wei CY; Zhang PF; Gao DM; Chen J; Zhao Y; Dong SS; Liu BB
J Exp Clin Cancer Res; 2019 Sep; 38(1):409. PubMed ID: 31533816
[TBL] [Abstract] [Full Text] [Related]
3. Testicular orphan receptor 4 promotes tumor progression and implies poor survival through AKT3 regulation in seminoma.
Chen Y; Lu J; Xia L; Xue D; Yu X; Shen D; Xu L; Li G
Cancer Sci; 2018 Feb; 109(2):384-394. PubMed ID: 29197138
[TBL] [Abstract] [Full Text] [Related]
4. Autophagy supports generation of cells with high CD44 expression via modulation of oxidative stress and Parkin-mediated mitochondrial clearance.
Whelan KA; Chandramouleeswaran PM; Tanaka K; Natsuizaka M; Guha M; Srinivasan S; Darling DS; Kita Y; Natsugoe S; Winkler JD; Klein-Szanto AJ; Amaravadi RK; Avadhani NG; Rustgi AK; Nakagawa H
Oncogene; 2017 Aug; 36(34):4843-4858. PubMed ID: 28414310
[TBL] [Abstract] [Full Text] [Related]
